01—History
Shares Outstanding History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- 1.24B
1 older move runs past ±10% (largest −10.9%); point at, tap or drag across the bars to read one.
02—Ledger
Shares Outstanding, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | 1.24B | −0.4% | 10-K | |
| FY2024 | 1.25B | 0.0%flat | 10-K | |
| FY2023 | 1.25B | −0.1% | 10-K | |
| FY2022 | 1.25B | −0.6% | 10-K | |
| FY2021 | 1.25B | 0.0%flat | 10-K | |
| FY2020 | 1.25B | −0.9% | 10-K | |
| FY2019 | 1.27B | −1.2% | 10-K | |
| FY2018 | 1.28B | −2.0% | 10-K | |
| FY2017 | 1.31B | −0.2% | 10-K | |
| FY2016 | 1.31B | −7.9% | 10-K | |
| FY2015 | 1.42B | −5.1% | 10-K | |
| FY2014 | 1.50B | −2.3% | 10-K | |
| FY2013 | 1.53B | +1.0% | 10-K | |
| FY2012 | 1.52B | +0.9% | 10-K | |
| FY2011 | 1.51B | −6.1% | 10-K | |
| FY2010 | 1.60B | −10.9% | 10-K | |
| FY2009 | 1.80B | −1.1% | 10-K | |
| FY2008 | 1.82B | — | 10-K |
03—Questions
What is shares outstanding?
Shares outstanding is the total number of common shares currently held by all shareholders, including restricted shares.
What is GILEAD SCIENCES, INC.'s current shares outstanding?
GILEAD SCIENCES, INC. (GILD) annual shares outstanding for 2025 was 1.24B, a 0.40% decline from 2024. GILEAD SCIENCES, INC. shares outstanding for the quarter ending March 31, 2026 was 1.24B.
What was GILEAD SCIENCES, INC.'s shares outstanding in 2024?
GILEAD SCIENCES, INC. annual shares outstanding for 2024 was 1.25B, a 0.00% increase from 2023.
What was GILEAD SCIENCES, INC.'s shares outstanding in 2023?
GILEAD SCIENCES, INC. annual shares outstanding for 2023 was 1.25B, a 0.08% decline from 2022.
What is GILEAD SCIENCES, INC.'s 5-year shares outstanding CAGR?
GILEAD SCIENCES, INC. shares outstanding grew at a compound annual growth rate (CAGR) of 0.21% from FY2020 to FY2025, going from 1.25B to 1.24B over 5 years.
- Company
- GILEAD SCIENCES, INC.
- Ticker
- GILD
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)